eViralHepatitis Review eViralHepatitis Review eViralHepatitis Review
eViralHepatitis Review
blue block sp

Mark S. Sulkowski, MD
Professor of Medicine
Medical Director, Viral Hepatitis Center
Divisions of Infectious Diseases and Gastroenterology/Hepatology
The Johns Hopkins University School of Medicine
Baltimore, Maryland

Dr. Sulkowski received his MD from Temple University School of Medicine and completed a fellowship in infectious diseases at Johns Hopkins University School of Medicine. Dr. Sulkowski has been the principal investigator for numerous clinical trials of agents for treating viral hepatitis, including novel agents. He is the co-investigator for adult patients at the Johns Hopkins site of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Hepatitis B Clinical Research Network. Dr. Sulkowski is a member of numerous professional societies, including the American Association for the Study of Liver Diseases, the European Association for the Study of the Liver, and the Infectious Diseases Society of America. He has published widely, with papers in the Annals Internal Medicine, New England Journal of Medicine, Journal of the American Medical Association, Journal of Infectious Diseases, and Hepatology. As an invited lecturer, he has discussed the management of viral hepatitis at numerous, major national and international medical meetings.

Faculty Disclosure
Mark S. Sulkowski discloses that he has received grants for Abbott, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol Myers-Squibb, Gilead, Janssen, Merck, Roche, Vertex and has served as a consultant for Abbott, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol Myers-Squibb, Gilead, Janssen, Merck, Novartis, Pfizer, Roche, and Vertex.

Raymond T. Chung, MD
Associate Professor of Medicine
Director of Hepatology
Harvard Medical School
Vice Chief of Gastroenterology
Massachusetts General Hospital
Boston, Massachusetts

Dr. Raymond T. Chung is Director of Hepatology and Vice Chief of Gastroenterology at Massachusetts General Hospital. He has been an international leader in the study of HCV pathogenesis, and his laboratory has made several major contributions to the understanding of HCV-related liver disease. He has been principal investigator of the NIH-funded Cooperative Center for Human Immunology for the Study of Hepatitis C Persistence. He has also contributed greatly to the study of mechanisms of liver disease in HCV-HIV coinfection. To that end, he is currently vice chair of the Hepatitis Transformative Science Group of the NIH AIDS Clinical Trials Group, which has been charged with developing innovative clinical trials in HCV monoinfection and HCV-HIV coinfection. He is also site principal investigator for the NIH Hepatitis B Research Network consortium and the US Acute Liver Failure Study Group. Dr. Chung serves on the Steering Committee of the HCV Special Interest Group of the AASLD and was recently elected to the Governing Board of the AASLD. Dr. Chung has been widely sought after as a speaker on viral hepatitis and has earned numerous teaching awards from Massachusetts General Hospital and Harvard Medical School.

Faculty Disclosure
Raymond T. Chung, MD discloses that he has served as a consultant for Enanta and Idenix.

Julie McArthur, MS, CRNP
Adult Nurse Practitioner
Division of Infectious Disease
The Johns Hopkins University School of Medicine
Baltimore, Maryland

Julie McArthur received an AA Nursing degree in 1980, followed by a bachelor's degree in Nursing in 1986 from the College of Notre Dame, Baltimore, Maryland. Ten years later she received a master's degree in Nursing from the University of Maryland School of Nursing in 1996. She received the Master's Thesis Research Award for her work on a neuropathy screening instrument.

Ms. McArthur started working in the HIV field in 1986, initially in a nursing research role for the MACS cohort, a large multicenter natural history study of HIV infection. Later, she became a nurse research coordinator for clinical trials at Chase-Brexton Health Services (CHBS), a freestanding outpatient HIV and primary care clinic in Baltimore.

After becoming a nurse practitioner, she continued her work at CBHS as an HIV medical provider. Her interest in hepatitis C began in 1997, when she started a hepatitis C treatment clinic at CBHS. She then worked as a medical provider at the Johns Hopkins Bloomberg School of Public Health on a research study, Acute and Early HIV infection. She also worked at the Center for Immunization Research at JHU Bloomberg School of Public Health evaluating Phase 1 vaccine trials for infectious disease.

She currently works in the Moore Clinic, a large outpatient hospital-based HIV clinic at The Johns Hopkins Hospital and is directly responsible for the medical care for approximately 150 patients with HIV and hepatitis co-infection. She has lectured regularly on the management of hepatitis C in CME activities. She serves as a clinical preceptor at the AIDS Education Training Center for the education of nurse practitioners and physician assistants on the evaluation and management of hepatitis B and C.

Faculty Disclosure
No other planners have indicated that they have any financial interests or relationships with a commercial entity.


Newsletter Header

CME/CNE Information

Current Newsletter

Recommend to a colleague

Hepatitis B Foundation
Hepatitis C Association

JHU Logo
The Institute for Johns Hopkins Nursing

Share on Facebook